Home »
Different groups of drugs are used for the treatment of rheumatic conditions. They are intended to suppress the rogue immune system which attacks its own body. It is unclear to date whether the use of immunosuppressants increases the risk of a severe course in case of an infection with the novel coronavirus SARS-CoV-2. A current […]
Patients with heart failure who experience low health literacy are at an increased risk of hospitalization and mortality. This finding has significant clinical and public health implications and suggests that assessing and intervening upon an individual’s understanding of their own health could improve heart failure outcomes, according to research published in JACC: Heart Failure. Heart […]
A small study in Greece found that the clinically approved anti-inflammatory drug anakinra, used to treat rheumatoid arthritis, improved respiratory function in patients with severe coronavirus disease 2019 (COVID-19). The eight patients also had a condition called secondary hemophagocytic lymphohistiocytosis (sHLH), which is characterized by overactivation of the immune system and organ failure. One patient, […]
Reprogramming a patient’s own skin cells to replace cells in the brain that are progressively lost during Parkinson’s disease (PD) has been shown to be technically feasible, reports a team of investigators from McLean Hospital and Massachusetts General Hospital (MGH) in the most recent issue of the New England Journal of Medicine. PD is the […]
Chinese study finds up to 30% of coronavirus patients hardly develop ANY antibodies against the infection – raising concerns many who recover from COVID-19 are not immune Fudan University researchers tested 175 recovered coronavirus patients for antibodies against the virus Antibodies are generated after someone has contracted a virus and generally help them fight off […]
In a small clinical trial just granted approval, about 30 COVID-19 patients at Karolinska University Hospital may soon begin to receive blood plasma from people who have recovered from the disease. Sweden’s Ethical Review Authority has approved the trial treatment, and its effectiveness will be evaluated in a study by researchers at Karolinska Institutet and […]
Three months after undergoing renal denervation (RDN)—a procedure that delivers energy to overactive nerves leading to the kidney to decrease their activity—patients with untreated high blood pressure had statistically significant reductions in average blood pressure over 24 hours compared with patients who underwent a sham procedure and experienced no major adverse effects, according to results […]
As more people recover from COVID-19, that means more people should have antibodies against the virus. And it’s possible that blood donations from those survivors could help protect or treat other people, according to some infectious disease experts. The general notion is far from new. In the first half of the 20th century, doctors used […]
More than 80% of coronavirus patients only get mild symptoms, like a cough and fever, and most recover quickly from their infections, Chinese data reveals Data published by the Chinese CDC suggest that 81% of COVID-19 patients only develop mild symptoms like cough, fever and aches Coronavirus became severe in 15 percent of cases and […]
The first UK clinical trial to increase the identification and treatment of hepatitis C (HCV) patients in primary care has been found to be effective, acceptable to staff and highly cost-effective for the NHS. The University of Bristol-led Hepatitis C Assessment to Treatment Trial (HepCATT), published in the British Medical Journal today, provides robust evidence […]